Guidance

Windsor Framework explainer

Explainer for industry on the main changes introduced by the Windsor Framework on the supply of medicines in Northern Ireland.

From:
Medicines and Healthcare products Regulatory Agency
Published
20 November 2024
Last updated
11 March 2025 — See all updates

Documents

Windsor Framework agreement on the supply of medicines in Northern Ireland explained

HTML

Windsor Framework agreement on the supply of medicines in Northern Ireland explained

PDF, 740 KB, 35 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

An explainer document for the pharmaceutical industry which brings together in a simpler format the information published in our Windsor Framework guidance collection. This page explains the main changes that implementing the Windsor Framework will introduce on 1 January 2025 and what you need to do to prepare.

Updates to this page

Published 20 November 2024
Last updated 11 March 2025 + show all updates

  1. Updated to remove: “1. Subject to the UK providing written guarantees to the European Commission as provided for in Article 8 of EU Regulation 2023/1182 and following the entry into force and application procedure provided for in Article 14” from document Windsor Framework agreement on the supply of medicines in Northern Ireland explained

  2. Added HTML version of 'Windsor Framework agreement on the supply of medicines in Northern Ireland explained'

  3. First published.

Sign up for emails or print this page

Related content